{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:34:03Z","timestamp":1787726043970,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Henan Medical Science and Technology Research Program","award":["LHGJ20220359"],"award-info":[{"award-number":["LHGJ20220359"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273229"],"award-info":[{"award-number":["82273229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neuroendocrine carcinoma (NEC) originating from the endometrium is rare, and there is limited knowledge regarding its diagnosis and optimal management. In this study, we present our experience with 11 patients with endometrial NEC, aiming to provide guidance for clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively collected the clinical, pathological, and treatment data of 11 patients with endometrial NEC who were treated at the First Affiliated Hospital of Zhengzhou University from January 2011 to July 2023. The clinicopathological characteristics, treatment and prognosis of these patients were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median age of the patients was 55.0 (39.0\u201364.0) years, and the median tumor size was 40.0 (33.0\u201360.0)\u00a0mm. Irregular vaginal bleeding was the most common symptom observed in 10 out of 11 patients, while metabolic syndrome occurred in only 2 out of 11 patients. Six out of the 11 patients were diagnosed at an early stage. Among the patients, 6 were diagnosed with endometrial NECs, while the remaining patients had a combination of endometrial NEC and other non-NEC endometrial carcinomas. All patients underwent surgery, except for one who received only chemotherapy due to multiple metastases. After surgery, adjuvant chemotherapy was administered to 5 patients, chemotherapy combined with radiotherapy was given to 3 patients, and 2 patients did not receive any adjuvant therapy. A total of 10 patients completed the follow-up, with a median follow-up time of 51.0 (14.3\u201381.0) months. Unfortunately, 2 patients died from the disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>NECs originating from the endometrium might not be affected by metabolic disorders. Preoperative diagnosis of these tumors was challenging. The primary approach for managing endometrial NEC can be multimodal treatment centered around surgery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12393-5","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T20:20:54Z","timestamp":1716582054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neuroendocrine carcinoma of the endometrium: a retrospective analysis of data from a single center"],"prefix":"10.1186","volume":"24","author":[{"given":"Xueyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanpeng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"issue":"1","key":"12393_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"12393_CR2","doi-asserted-by":"crossref","unstructured":"Tian Y, Lai T, Li Z, Mao M, Jin Y, Liu Y, Guo R. Role of non\u2013coding RNA intertwined with the Wnt\/beta\u2013catenin signaling pathway in endometrial cancer (review). Mol Med Rep. 2023;28(2).","DOI":"10.3892\/mmr.2023.13037"},{"key":"12393_CR3","doi-asserted-by":"crossref","unstructured":"Virarkar M, Vulasala SS, Morani AC, Waters R, Gopireddy DR, Kumar S, Bhosale P, Lall C. Neuroendocrine neoplasms of the gynecologic tract. Cancers (Basel). 2022;14(7).","DOI":"10.3390\/cancers14071835"},{"key":"12393_CR4","doi-asserted-by":"publisher","first-page":"921615","DOI":"10.3389\/fonc.2022.921615","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Pang L. Primary neuroendocrine tumors of the endometrium: management and outcomes. Front Oncol. 2022;12:921615.","journal-title":"FRONT ONCOL"},{"issue":"6","key":"12393_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3892\/ol.2023.13815","volume":"25","author":"Y Liao","year":"2023","unstructured":"Liao Y, Cao W, Li Z, Xu X, Zhang Y, Liu Z, Miao J, Zhou Y, Zhen Z, Liu D, et al. Gallbladder neuroendocrine carcinoma: a report of two cases and literature review. Oncol Lett. 2023;25(6):229.","journal-title":"ONCOL LETT"},{"issue":"12","key":"12393_CR6","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31(12):1770\u201386.","journal-title":"Mod Pathol"},{"issue":"10","key":"12393_CR7","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.3390\/curroncol29100587","volume":"29","author":"HK Park","year":"2022","unstructured":"Park HK. Neuroendocrine carcinomas of the uterine cervix, endometrium, and ovary show higher tendencies for bone, brain, and liver organotrophic metastases. Curr Oncol. 2022;29(10):7461\u20139.","journal-title":"CURR ONCOL"},{"issue":"2","key":"12393_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ygyno.2019.09.004","volume":"155","author":"K Schlechtweg","year":"2019","unstructured":"Schlechtweg K, Chen L, St CC, Tergas AI, Khoury-Collado F, Hou JY, Melamed A, Neugut AI, Hershman DL, Wright JD. Neuroendocrine carcinoma of the endometrium: disease course, treatment, and outcomes. Gynecol Oncol. 2019;155(2):254\u201361.","journal-title":"GYNECOL ONCOL"},{"issue":"2","key":"12393_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"S Pecorelli","year":"2009","unstructured":"Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103\u20134.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"12393_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens L, Ezzat S, de Herder WW, Klimstra DS, Papotti M, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022;33(1):115\u201354.","journal-title":"ENDOCR PATHOL"},{"issue":"5","key":"12393_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/PAS.0000000000000633","volume":"40","author":"CE Pocrnich","year":"2016","unstructured":"Pocrnich CE, Ramalingam P, Euscher ED, Malpica A. Neuroendocrine carcinoma of the endometrium: a clinicopathologic study of 25 cases. Am J Surg Pathol. 2016;40(5):577\u201386.","journal-title":"AM J SURG PATHOL"},{"key":"12393_CR12","doi-asserted-by":"publisher","first-page":"780769","DOI":"10.3389\/fendo.2021.780769","volume":"12","author":"X Yang","year":"2021","unstructured":"Yang X, Li X, Dong Y, Fan Y, Cheng Y, Zhai L, Zhang S, Zhou J, Wang J. Effects of metabolic syndrome and its components on the prognosis of endometrial cancer. Front Endocrinol (Lausanne). 2021;12:780769.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"12393_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.tjog.2013.05.006","volume":"53","author":"YJ Koo","year":"2014","unstructured":"Koo YJ, Kim DY, Kim KR, Kim JH, Kim YM, Kim YT, Nam JH. Small cell neuroendocrine carcinoma of the endometrium: a clinicopathologic study of six cases. Taiwan J Obstet Gynecol. 2014;53(3):355\u20139.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"12393_CR14","unstructured":"Tullio Golia D\u2019Aug\u00e81 AG. 2, Giorgio Bogani3, Camilla Di Dio1, Antonio Simone Lagan\u00e04, Violante Di Donato1, Maria Giovanna Salerno5, Donatella Caserta6, Vito Chiantera4, Enrico Vizza7, Ludovico Muzii1, Ottavia D\u2019Oria2,5,*: prevention, screening, treatment and follow-up of gynecological cancers: state of art and future perspectives. Clin Exp Obstet Gyn. 2023."},{"issue":"6","key":"12393_CR15","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.3802\/jgo.2019.30.e103","volume":"30","author":"H Matsumoto","year":"2019","unstructured":"Matsumoto H, Shimokawa M, Nasu K, Shikama A, Shiozaki T, Futagami M, Kai K, Nagano H, Mori T, Yano M, et al. Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai clinical oncology group\/intergroup study in Japan. J Gynecol Oncol. 2019;30(6):e103.","journal-title":"J GYNECOL ONCOL"},{"issue":"3","key":"12393_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2463\/mrms.mp.2020-0056","volume":"20","author":"K Kitajima","year":"2021","unstructured":"Kitajima K, Kihara T, Kawanaka Y, Takahama J, Ueno Y, Murakami T, Yoshida K, Kato F, Takahata A, Fukukura Y, et al. Characteristics of MR imaging for staging and survival analysis of neuroendocrine carcinoma of the endometrium: a multicenter study in Japan. Magn Reson Med Sci. 2021;20(3):236\u201344.","journal-title":"MAGN RESON MED SCI"},{"issue":"5","key":"12393_CR17","doi-asserted-by":"publisher","first-page":"101897","DOI":"10.1016\/j.jogoh.2020.101897","volume":"50","author":"U Akgor","year":"2021","unstructured":"Akgor U, Kuru O, Sakinci M, Boyraz G, Sen S, Cakir I, Turan T, Gokcu M, Gultekin M, Sayhan S, et al. Neuroendocrine carcinoma of the endometrium: a very rare gynecologic malignancy. J Gynecol Obstet Hum Reprod. 2021;50(5):101897.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"1","key":"12393_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1515\/biol-2021-0122","volume":"16","author":"W Hou","year":"2021","unstructured":"Hou W, Zhou B, Hou G, Pang Y, Sang J, Li N. Small cell neuroendocrine carcinoma expressing alpha fetoprotein in the endometrium. Open Life Sci. 2021;16(1):1219\u201324.","journal-title":"OPEN LIFE SCI"},{"issue":"2","key":"12393_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","volume":"21","author":"N Abu-Rustum","year":"2023","unstructured":"Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, et al. Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(2):181\u2013209.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"12393_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","volume":"122","author":"GJ Gardner","year":"2011","unstructured":"Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol. 2011;122(1):190\u20138.","journal-title":"GYNECOL ONCOL"},{"issue":"9","key":"12393_CR21","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.bulcan.2018.06.007","volume":"105","author":"FM Sidibe","year":"2018","unstructured":"Sidibe FM, Traore Z, Georgala A, Kanab R, Larsimont D, Awada A, Piccart-Gebhart M. Small cell carcinoma of the endometrium: a clinicopathological study and management of three cases. Bull Cancer. 2018;105(9):842\u20136.","journal-title":"Bull Cancer"},{"key":"12393_CR22","doi-asserted-by":"crossref","unstructured":"Hardy LE, Chaudry Z, Wan K, Ayres C. Primary mixed large cell neuroendocrine and high grade serous carcinoma of the endometrium. BMJ Case Rep. 2020;13(9).","DOI":"10.1136\/bcr-2020-234977"},{"issue":"5","key":"12393_CR23","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1136\/ijgc-00009577-200409000-00041","volume":"14","author":"A Katahira","year":"2004","unstructured":"Katahira A, Akahira J, Niikura H, Ito K, Moriya T, Matsuzawa S, Makinoda S, Oda T, Fujiwara K, Yaegashi N. Small cell carcinoma of the endometrium: report of three cases and literature review. Int J Gynecol Cancer. 2004;14(5):1018\u201323.","journal-title":"INT J GYNECOL CANCER"},{"key":"12393_CR24","doi-asserted-by":"crossref","unstructured":"Pappa C, Le Thanh V, Smyth SL, Zouridis A, Kashif A, Sadeghi N, Sattar A, Damato S, Abdalla M, Lagana AS et al. Mixed endometrial epithelial carcinoma: epidemiology, treatment and survival rates-a 10-year retrospective cohort study from a single institution. J Clin Med. 2023;12(19).","DOI":"10.3390\/jcm12196373"},{"issue":"5","key":"12393_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409\u201336.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"12393_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.annonc.2022.05.519","volume":"33","author":"M Maio","year":"2022","unstructured":"Maio M, Ascierto PA, Manzyuk L, Motola-Kuba D, Penel N, Cassier PA, Bariani GM, De Jesus AA, Doi T, Longo F, et al. Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study. Ann Oncol. 2022;33(9):929\u201338.","journal-title":"ANN ONCOL"},{"key":"12393_CR27","doi-asserted-by":"crossref","unstructured":"Di Donato V, Giannini A, Bogani G. Recent advances in endometrial cancer management. J Clin Med. 2023;12(6).","DOI":"10.3390\/jcm12062241"},{"key":"12393_CR28","doi-asserted-by":"crossref","unstructured":"Dellino M, Cerbone M, Lagana AS, Vitagliano A, Vimercati A, Marinaccio M, Baldini GM, Malvasi A, Cicinelli E, Damiani GR et al. Upgrading treatment and molecular diagnosis in endometrial cancer-driving new tools for endometrial preservation? Int J Mol Sci. 2023;24(11).","DOI":"10.3390\/ijms24119780"},{"issue":"6349","key":"12393_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409\u201313.","journal-title":"Science"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12393-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12393-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12393-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T20:22:39Z","timestamp":1716582159000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12393-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12393"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12393-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"6 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patients provided written informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of the data and images in this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"636"}}